Mostrar el registro sencillo del ítem

dc.contributor.authorNavarro López, Vicente
dc.contributor.otherSánchez Pellicer, Pedro
dc.date.accessioned2024-05-09T12:36:14Z
dc.date.available2024-05-09T12:36:14Z
dc.date.issued2024
dc.identifier.urihttp://hdl.handle.net/10952/7702
dc.description.abstractRandomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy adult population.es
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPreventiones
dc.subjectUpper respiratory tract infectionses
dc.subjectProbioticses
dc.subjectMicrobiotaes
dc.subjectMicrobiomees
dc.titleRandomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a probiotic preparation in the prevention of upper respiratory tract infections in a healthy adult populationes
dc.title.alternativeClinical trial to evaluate the efficacy of a probiotic preparation in the prevention of upper respiratory tract infections in adultses
dc.typeotheres
dc.rights.accessRightsopenAccesses
dc.description.disciplineMedicinaes


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional